King Wealth Management Group

Position in INSM — INSMED Inc

CIK 1568235 SARATOGA SPRINGS, NY

Position in INSM

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$213,240

New position

Shares Held

2,000

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#481

of 663 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

King Wealth Management Group holds $1,215,114 across 5 Biotechnology names. INSM ranks #3 (17.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTGX	Protagonist Therapeutics, Inc	4,000	$490,320
2	DFTX	Definium Therapeutics, Inc.	10,000	$470,400
3	INSM	INSMED Inc This page	2,000	$213,240
4	ALDX	Aldeyra Therapeutics, Inc.	12,700	$27,051
5	HRTX	Heron Therapeutics, Inc. /De/	32,799	$14,103

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$213,240	2,000	—	Shares	Sole	2026-08-05
No filing history on record for this holder in this stock.